Although such cancer cells can cope with the increased protein load via an adaptive ER stress‐induced survival pathway [51], they are less able to tolerate any further increased protein challenge, contributing to our observation of increased proteasome inhibitor sensitivity in at least some MYC‐hyperactive PDACs. Here, MYC is linked to cancer.